City of Hope is recognized internationally for its breakthrough research discoveries and clinical treatments for lymphoma and related disorders such as leukemia, myeloma and myelodysplastic syndromes.
A pioneer in the field of hematopoietic cell transplantation (HCT), we have performed more than 8,500 bone marrow and stem cell transplants to date and operate one of the largest, most successful programs of its kind in the world, with many patients experiencing long-lasting remissions and even cures.
We conduct clinical trials using innovative combination chemotherapy protocols which have produced impressive results in a variety of lymphomas and leukemias.
Our team of specialists is renowned for its collaborative and compassionate approach, combining highly advanced technologies, aggressive therapies and an extensive support network to give patients the best outcomes possible.